Pioglitazone improves insulin sensitivity, reduces visceral fat and stimulates lipolysis in non diabetic dialyzed patients

• Main Authors: Anne Zanchi (Author), Luc Tappy (Author), Nicolas Theumann (Author), Georges Halabi (Author), Thierry Gauthier (Author), Claudine Mathieu (Author), Sylvie Tremblay (Author), Pauline Coti Michel (Author), Burnier Daniel Teta (Author)
• Format: Book
• Published: The Korean Society of Nephrology, 2012-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Insulin resistance is common in dialyzed patients and is associated with increased mortality and protein-energy wasting. The aim of this study was to investigate the effect of pioglitazone (PIO), a powerful insulin sensitizer, on insulin sensitivity, body composition and adipose tissue metabolism, i...